pacadd135 (DSMZ)
93
Structured Review
DSMZ
pacadd135
Pacadd135, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pacadd+135/PACADD-135/bio_rxiv__2025__08__06__668944-194-0-8
Average 93 stars, based on 4 article reviews
Pacadd135, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pacadd+135/PACADD-135/bio_rxiv__2025__08__06__668944-194-0-8
Average 93 stars, based on 4 article reviews
pacadd135 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
other:Article Title: Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Cell Lines 510 PATC43 and PATC50 cell lines were provided by J. Fleming (MD Anderson Cancer Center); RWP1, FA6 and Paca44 were from N. Lemoine (Barts Cancer Institute, London, UK); IMIM-PC-1, SK-PC-1 and SK-PC-3 from F. Real (Center Nacional de Investigaciones Oncologicas, Spain); MDAPanc-48 and MDAPanc-81 from E. Frazier (MD Anderson Cancer Center); L3.3 and FG from I. Fidler (MD Anderson Cancer 515 Center); A818 from H. Article Title: Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: Cell Lines PATC43 and PATC50 cell lines were provided by J. Fleming (MD Anderson Cancer Center); RWP1, FA6 and Paca44 were from N. Lemoine (Barts Cancer Institute, London, UK); IMIM-PC-1, SK-PC-1 and SK-PC-3 from F. Real (Center Nacional de Investigaciones Oncologicas, Spain); MDAPanc-48 and MDAPanc-81 from E. Frazier (MD Anderson Cancer Center); L3.3 and FG from I. Fidler (MD Anderson Cancer Center); A818 from H. Article Title: Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer Article Snippet: PATC43 and PATC50 cell lines were provided by J. Fleming (MD Anderson Cancer Center); RWP1, FA6 and Paca44 were from N. Lemoine (Barts Cancer Institute, London, UK); IMIM-PC-1, SK-PC-1 and SK-PC-3 from F. Real (Center Nacional de Investigaciones Oncologicas, Spain); MDAPanc-48 and MDAPanc-81 from E. Frazier (MD Anderson Cancer Center); L3.3 and FG from I. Fidler (MD Anderson Cancer Center); A818 from H. Cell Culture:Article Title: Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype Article Snippet: The lines B211, B290, huPDAC11, huPDAC3, huPDAC7, huPDAC17, PDC40, PDC49, PDC56, PDC117, PDC148, and huPDAC1 were cultured in RPMI GlutaMAX® (#61870036, Life Technologies, Darmstadt, Germany) supplemented with 20% FCS and 1% Penicillin-Streptomycin (Merck, Sigma-Aldrich, Darmstadt, Germany). .. The lines PACADD-119, PACADD-135, PACADD-137, PACADD-159, |